BSFAF
Price
$0.04
Change
-$0.01 (-20.00%)
Updated
Oct 18 closing price
MBCOF
Price
$0.11
Change
+$0.01 (+10.00%)
Updated
Dec 16 closing price
Ad is loading...

BSFAF vs MBCOF

Header iconBSFAF vs MBCOF Comparison
Open Charts BSFAF vs MBCOFBanner chart's image
BSF Enterprise
Price$0.04
Change-$0.01 (-20.00%)
Volume$5K
CapitalizationN/A
MARVEL BIOSCIENCES
Price$0.11
Change+$0.01 (+10.00%)
Volume$11.5K
CapitalizationN/A
BSFAF vs MBCOF Comparison Chart
Loading...
BSFAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBCOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSFAF vs. MBCOF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSFAF is a Buy and MBCOF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BSFAF: $0.04 vs. MBCOF: $0.11)
Brand notoriety: BSFAF and MBCOF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BSFAF: 107% vs. MBCOF: 103%
Market capitalization -- BSFAF: $3.11M vs. MBCOF: $4.56M
BSFAF [@Biotechnology] is valued at $3.11M. MBCOF’s [@Biotechnology] market capitalization is $4.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSFAF’s FA Score shows that 1 FA rating(s) are green whileMBCOF’s FA Score has 1 green FA rating(s).

  • BSFAF’s FA Score: 1 green, 4 red.
  • MBCOF’s FA Score: 1 green, 4 red.
According to our system of comparison, MBCOF is a better buy in the long-term than BSFAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSFAF’s TA Score shows that 0 TA indicator(s) are bullish while MBCOF’s TA Score has 4 bullish TA indicator(s).

  • BSFAF’s TA Score: 0 bullish, 1 bearish.
  • MBCOF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both BSFAF and MBCOF are a bad buy in the short-term.

Price Growth

BSFAF (@Biotechnology) experienced а 0.00% price change this week, while MBCOF (@Biotechnology) price change was -5.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBCOF($4.56M) has a higher market cap than BSFAF($3.12M). MBCOF YTD gains are higher at: 51.983 vs. BSFAF (-76.119). BSFAF has higher annual earnings (EBITDA): -1.68M vs. MBCOF (-2.02M). BSFAF has more cash in the bank: 1.37M vs. MBCOF (218K). BSFAF has less debt than MBCOF: BSFAF (118K) vs MBCOF (1.5M). BSFAF has higher revenues than MBCOF: BSFAF (67.2K) vs MBCOF (0).
BSFAFMBCOFBSFAF / MBCOF
Capitalization3.12M4.56M68%
EBITDA-1.68M-2.02M83%
Gain YTD-76.11951.983-146%
P/E RatioN/AN/A-
Revenue67.2K0-
Total Cash1.37M218K630%
Total Debt118K1.5M8%
TECHNICAL ANALYSIS
Technical Analysis
BSFAFMBCOF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
3%
Bearish Trend 2 days ago
57%
TrendMonth
ODDS (%)
N/A
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
50%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BSFAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBCOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCESX15.14N/A
N/A
Virtus KAR Emerging Markets Small-Cap C
TIRHX18.65N/A
N/A
Nuveen Real Estate Sec Sel I
RAPCX10.04-0.05
-0.50%
Cohen & Steers Real Assets C
APGZX113.27-0.78
-0.68%
AB Large Cap Growth Z
LEVIX9.92-0.13
-1.29%
Lazard US Equity Concentrated Instl

BSFAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSFAF has been closely correlated with BIESF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSFAF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSFAF
1D Price
Change %
BSFAF100%
N/A
BIESF - BSFAF
82%
Closely correlated
N/A
SOLTF - BSFAF
29%
Poorly correlated
-2.01%
YECO - BSFAF
24%
Poorly correlated
N/A
APLM - BSFAF
21%
Poorly correlated
-8.87%
CERO - BSFAF
21%
Poorly correlated
+19.80%
More

MBCOF and

Correlation & Price change

A.I.dvisor tells us that MBCOF and XENE have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBCOF and XENE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBCOF
1D Price
Change %
MBCOF100%
N/A
XENE - MBCOF
20%
Poorly correlated
-0.07%
AWKNF - MBCOF
20%
Poorly correlated
N/A
BSFAF - MBCOF
8%
Poorly correlated
N/A
ZEOX - MBCOF
6%
Poorly correlated
-7.92%
ATYR - MBCOF
5%
Poorly correlated
+1.65%
More